Acceleron Pharma 2017 J.P. Morgan Healthcare Conference

Acceleron Pharma presented its clinical-stage biopharmaceutical pipeline at the 35th Annual J.P. Morgan Healthcare Conference in January 2017. The company highlighted its strategy to build a fully integrated firm through multiple Phase 3 trials, expanding hematology programs including a high-value collaboration with Celgene, and six clinical candidates with significant near-term value inflection points.